Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS),..

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its..

Covishield was developed by AstraZeneca in collaboration with the Oxford University during the COVID-19 pandemic

AstraZeneca, in collaboration with the University of Oxford, has acknowledged that its COVID-19 vaccine carries the risk of causing a rare side effect known as..

An India born prolific lawyer, Ajit Mishra, has been conferred with "*Freedom of the City of London Award*" at Guildhall today for his outstanding contribution..

Canada signed a contract with AstraZeneca in 2020 to get 20 million doses of its vaccine, and 2.3 million Canadians received at least one dose of it.

The year began on a promising note as Bangladesh PM Sheikh Hasina thanked her Indian counterpart Narendra Modi for sending over two million doses of..

The Lancet study reportedly stated that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months.

The company said researchers at Oxford University who carried out the study were independent of those who worked on the vaccine with AstraZeneca.

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world`s largest maker of vaccines and the producer of a version of the..

Future pandemics could be even more lethal than Covid-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is..

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the..

The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India. Covishield, the..

Previously, MI5 operatives have stated that multiple cyber strikes on Oxford University were attempted by Russian hackers on March 2020. This was a month after..

Previously, MI5 operatives have stated that multiple cyber strikes on Oxford University were attempted by Russian hackers on March 2020. This was a month after..

The UK government has assured that it is working with India on “a phased approach” to its international travel norms. The development came after the UK..

The nerve disorder is listed in the lowest occurrence category of possible side-effects of the Oxford AstraZeneca vaccine, as "very rare."

Two doses of either vaccine still provided at least the same level of protection as having had COVID-19 before through natural infection, the Oxford-based..

Johnson & Johnson's COVID-19 vaccine has received emergency use approval (EUA) in India, becoming the fifth vaccine to be approved after Oxford-AstraZeneca's..

Covishield is now recognised and accepted Oxford-Astrazeneca vaccine for entry of international travellers.

Covishield is now recognised and accepted Oxford-Astrazeneca vaccine for entry of international travellers.

The study says the Oxford AstraZeneca vaccine, a version of which is manufactured as Covishield in India, might offer protection lasting a lifetime.

The second wave of coronavirus highlighted not just the unpredictability of the SARs-COV-2 virus but also emphasized on the importance of COVID vaccines. As of..

The Wimbledon spectators also applauded the efforts of organisations that have contributed to Britain's fight against COVID-19.

Even though Covishield has the WHO’s approval, the ‘Green Pass’ program only accommodates EMA-approved vaccines. The four COVID-19 vaccines approved by..

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in..

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in..

Canada`s National Advisory Committee on Immunizations (NACI) said that those who received the first shot of Oxford-AstraZeneca in their vaccination schedule can..

Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by..

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19,..

Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19,..

Public Health England (PHE) said that the two doses of the Oxford/AstraZeneca COVID-19 vaccine may provide around 85% to 90% effectiveness against COVID-19..

After the BioNTech Pfizer's COVID-19 vaccine, the Japanese government allows the use of Oxford AstraZeneca and Moderna vaccines for inoculation against..

Two doses of the Oxford/AstraZeneca Covid-19 vaccine are around 85% to 90% effective against symptomatic disease, Public Health England (PHE) said on Thursday,..

A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew..

A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first..

The Serum Institute chief spoke about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the..

New Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1...